Page last updated: 2024-08-22

ornithylaspartate and Encephalopathy, Hepatic

ornithylaspartate has been researched along with Encephalopathy, Hepatic in 73 studies

Research

Studies (73)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	8 (10.96)	18.2507
2000's	20 (27.40)	29.6817
2010's	42 (57.53)	24.3611
2020's	3 (4.11)	2.80

Authors

Authors	Studies
Boutros, S; Saab, S; Winters, A; Yanny, B	1
Mahpour, NY; Pioppo-Phelan, L; Reja, M; Rustgi, VK; Tawadros, A	1
Alimirah, M; Gordon, SC; Sadiq, O	1
Goyal, O; Kaur, N; Kishore, H; Sharma, BC; Sidhu, SS	1
Arias, N; Hadjihambi, A; Jalan, R; Sheikh, M	1
Rathi, S; Taneja, S	1
Dahale, AS; Sachdeva, S; Sharma, BC; Srivastava, S; Varakanahalli, S	1
Gluud, LL; Goh, ET; Morgan, MY; Sidhu, SS; Stokes, CS; Vilstrup, H	1
Cai, XJ; Hu, CM; Wang, L	1
Abdo-Francis, JM; Alla, SN; Camacho-Aguilera, J; Higuera-de-la-Tijera, F; Jiménez-Ponce, F; Pérez-Hernández, JL; Salas-Gordillo, F; Servín-Caamaño, AI	1
Butterworth, RF	2
Kircheis, G; Lüth, S	1
Butterworth, RF; McPhail, MJW	1
Alsahhar, JS; Rahimi, RS	1
Bogomolov, PO; Buyeverov, AO; Matsievich, MV; Mayev, IV; Uvarova, OV	1
Bai, M; Fan, D; Han, G; Qi, X; Yang, Z	1
Crossey, MM; Dhanjal, NS; Dresner, MA; Fitzpatrick, JA; Grover, VP; Leech, R; McPhail, MJ; Pflugrad, H; Saxby, BK; Taylor-Robinson, SD; Thomas, HC; Waldman, AD; Wesnes, K	1
Wang, RH; Xiang, JF; Yi, J; Zhong, XN; Zhou, BY; Zhou, ZW	1
Kutepov, DE; Pasechnik, IN; Sal'nikov, PS; Vershinina, MG	1
Bai, M; Bai, W; Cai, H; Fan, D; Guo, W; Han, G; He, C; Liu, L; Niu, J; Qi, X; Tie, J; Wang, J; Wang, Z; Wu, K; Xia, J; Yang, Z; Yin, Z	1
Manzhaliĭ, EH; Moĭseienko, VO; Nykula, TD; Solonovych, OS	1
Braddock, M; Chen, YP; Huang, GQ; Huang, S; Lin, YQ; Shi, KQ; Wang, LR; Zheng, MH; Zhu, GQ	1
Utzt, MJ	1
Henderson, PK; Herrera, JL	1
Sussman, NL	1
Petersen, KU	1
Ahn, JO; Chung, JY; Han, SM; Hwang, CY; Lee, YH; Li, Q; Youn, HY	1
Baranova, EN; Maksimov, SA; Plotnikova, EY	1
Achermann, P; Amodio, P; Angeli, P; Garrido, M; Montagnese, S; Raduazzo, D; Skorucak, J; Spinelli, G; Turco, M	1
Bak-Bol, A; Cook, NA; Cox, IJ; Crossey, MM; Dhanjal, NS; Fitzpatrick, JA; Grover, VP; McPhail, MJ; Morgan, MY; Saxby, BK; Southern, L; Taylor-Robinson, SD; Waldman, AD; Williams, R; Wylezinska-Arridge, M	1
Kircheis, G	1
Chen, YP; Jiang, Q; Jiang, XH; Zheng, MH	1
Ahmad, I; Alam, A; Butt, AK; Dilshad, A; Khan, AA; Malik, K; Sarwar, S; Shafqat, F	1
Ferenci, P; Gangl, A; König, F; Mittermaier, C; Peck-Radosavljevic, M; Schmid, M	1
Ameri, AA	1
Abdo-Francis, JM; Hernández-Vásquez, JR; Hinojosa-Ruiz, A; Pérez-Hernández, JL	1
Jalan, R; Noiret, L; Olde Damink, SW; Wright, G	1
Ndraha, S; Simadibrata, M	1
Krüger-Jansen, C; Lambert-Baumann, J; Oehler, G; Ong, JP; Younossi, ZM	1
Hasan, I; Ndraha, S; Simadibrata, M	1
Mittal, VV; Sarin, SK; Sharma, BC; Sharma, P	1
Abbas, Z; Abid, S; Hamid, S; Islam, M; Jafri, W; Mumtaz, K; Shah, HA	1
Evdokimov, VV; Evdokimova, AG; Kovalenko, EV; Radzevich, AÉ; Tomova, AV; Zhukolenko, LV	1
Blanco Vela, CI; Poo Ramírez, JL	1
Abdo Francis, JM; Higuera de la Tijera, F; Pérez Hernández, JL; Serralde-Zúñiga, AE	1
Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B	1
Wang, YM	1
Dahl, Sv; Häussinger, D; Kircheis, G; Wettstein, M	1
Carmona Soria, I; García Montes, JM; Herrerías Gutiérrez, JM; Jiménez Sáenz, M; Quero Guillén, JC	1
Häussinger, D; Wettstein, M	1
Bautista, JD; Grande, L; Ramos Guerrero, RM; Romero Gómez, M; Sánchez Muñoz, D	1
Gregor, M; Hass, HG; Hösl, F; Kaiser, S; Nägele, T; Seeger, U	1
Bernauer, E; Finsterer, J	1
Chen, CH; Chen, MF; Gao, XC; Li, RC	1
Iberer, F; Portugaller, HR; Stadlbauer, V; Stauber, RE; Stiegler, P; Tauss, J	1
Blei, A; Grüngreiff, K; Jalan, R; Kircheis, G; Marchesini, G; Morgan, MY; Riggio, O; Weissenborn, K	1
Dobkes, AL; Ermolov, SIu; Ermolova, TV; Kolesnikov, ME; Ovchinnikova, EV; Shabrov, AV	1
Bueverov, AO; Nadinskaia, MIu; Podymova, SD	1
Held, C; Kircheis, G; Krüger, B	1
Eisenburg, J	1
Albrecht, J; Hilgier, W; Januszewski, S; Quack, G	1
Jalan, R; Seery, JP; Taylor-Robinson, SD	1
Berndt, H; Buchner, M; Görtelmeyer, R; Held, C; Hendricks, R; Kircheis, G; Krüger, B; Kuklinski, B; Meister, H; Nilius, R; Otto, HJ; Rink, C; Rösch, W; Stauch, S	1
Adler, G; Beckh, K; Ditschuneit, H; Görtelmeyer, R; Hendricks, R; Heuser, A; Karoff, C; Kircheis, G; Malfertheiner, P; Mayer, D; Rösch, W; Stauch, S; Steffens, J	1
Butterworth, RF; Kircheis, G; Michalak, A; Pannunzio, P; Quack, G; Rose, C; Therrien, G	1
Koczorek, M	1
Delcker, A; Mihm, U; Pilatus, U; Raab, P; Rusch, O; Turowski, B; Zanella, FE; Zeuzem, S	1
Dicheva, DT; Iakovenko, EI; Lebedeva, EG; Maev, IV; V'iuchnova, ES	1

Reviews

27 review(s) available for ornithylaspartate and Encephalopathy, Hepatic

Article	Year
Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach. Clinics in liver disease, 2019, Volume: 23, Issue:4 Topics: Amino Acids, Branched-Chain; Ammonia; Caregivers; Cost of Illness; Dipeptides; Embolization, Therapeutic; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Neomycin; Patient Readmission; Rifaximin; Severity of Illness Index; Sodium Benzoate; Sorption Detoxification; Zinc	2019
Pharmacologic Management of Hepatic Encephalopathy. Clinics in liver disease, 2020, Volume: 24, Issue:2 Topics: Acarbose; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Dipeptides; Fecal Microbiota Transplantation; Flumazenil; GABA Modulators; Glycerol; Glycoside Hydrolase Inhibitors; Hepatic Encephalopathy; Humans; Lactulose; Laxatives; Phenylbutyrates; Probiotics; Rifaximin	2020
Novel Therapies in Hepatic Encephalopathy. Clinics in liver disease, 2020, Volume: 24, Issue:2 Topics: Acetylcarnitine; Albumins; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Flumazenil; GABA Modulators; Glycerol; Hepatic Encephalopathy; Humans; Nootropic Agents; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Surface-Active Agents	2020
Hepatic encephalopathy: a critical current review. Hepatology international, 2018, Volume: 12, Issue:Suppl 1 Topics: Albumins; Ammonia; Anti-Bacterial Agents; Bile Acids and Salts; Brain; Brain Edema; Cognitive Dysfunction; Dipeptides; Energy Metabolism; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Portasystemic Shunt, Surgical; Prognosis; Psychometrics; Severity of Illness Index; Synaptic Transmission	2018
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. The Cochrane database of systematic reviews, 2018, May-15, Volume: 5 Topics: Dipeptides; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Quality of Life; Randomized Controlled Trials as Topic	2018
Pharmacokinetic and Pharmacodynamic Properties of L-Ornithine L-Aspartate (LOLA) in Hepatic Encephalopathy. Drugs, 2019, Volume: 79, Issue:Suppl 1 Topics: Ammonia; Animals; Brain; Dipeptides; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Muscles; Rats; Signal Transduction	2019
L-Ornithine L-Aspartate (LOLA) for Hepatic Encephalopathy in Cirrhosis: Results of Randomized Controlled Trials and Meta-Analyses. Drugs, 2019, Volume: 79, Issue:Suppl 1 Topics: Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Secondary Prevention; Systematic Reviews as Topic; Treatment Outcome	2019
Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy. Current opinion in gastroenterology, 2019, Volume: 35, Issue:3 Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Frailty; Gastrointestinal Agents; Gastrointestinal Microbiome; Glycerol; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Rifaximin; Trace Elements; Zinc	2019
Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis. Metabolic brain disease, 2020, Volume: 35, Issue:1 Topics: Clinical Trials as Topic; Dipeptides; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Treatment Outcome	2020
l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:5 Topics: Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Randomized Controlled Trials as Topic; Treatment Outcome	2013
Systematic review with network meta-analysis: the comparative effectiveness and safety of interventions in patients with overt hepatic encephalopathy. Alimentary pharmacology & therapeutics, 2015, Volume: 41, Issue:7 Topics: Amino Acids, Branched-Chain; Ammonia; Dipeptides; Disaccharides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Mental Health; Neomycin; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin	2015
Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What? Clinics in liver disease, 2015, Volume: 19, Issue:3 Topics: Dipeptides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Patient Selection; Probiotics; Rifamycins; Rifaximin; Severity of Illness Index; Sickness Impact Profile	2015
Treatment of Overt Hepatic Encephalopathy. Clinics in liver disease, 2015, Volume: 19, Issue:3 Topics: Amino Acids, Branched-Chain; Ammonia; Arteriovenous Fistula; Dipeptides; Gastrointestinal Agents; Glycerol; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure; Malnutrition; Ornithine; Phenylbutyrates; Probiotics; Rifamycins; Rifaximin	2015
[HEPATIC ENCEPHALOPATHY AND TISSUE ZINC LEVELS IN LIVER DISEASE, DIAGNOSIS AND TREATMENT]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2015, Issue:7 Topics: Dipeptides; Hepatic Encephalopathy; Humans; Zinc	2015
Current state of knowledge of hepatic encephalopathy (Part V): clinical efficacy of L-ornithine-L-aspartate in the management of HE. Metabolic brain disease, 2016, Volume: 31, Issue:6 Topics: Animals; Dipeptides; Disease Management; Drug Administration Routes; Health Knowledge, Attitudes, Practice; Hepatic Encephalopathy; Humans; Randomized Controlled Trials as Topic; Treatment Outcome	2016
L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis. Journal of gastroenterology and hepatology, 2009, Volume: 24, Issue:1 Topics: Dipeptides; Hepatic Encephalopathy; Humans; Patient Selection; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome	2009
Interorgan ammonia metabolism in liver failure: the basis of current and future therapies. Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:2 Topics: Adipose Tissue; Amino Acids; Ammonia; Arginine; Brain; Dipeptides; Glutamate-Ammonia Ligase; Glutaminase; Hepatic Encephalopathy; Humans; Hyperammonemia; Intestinal Mucosa; Kidney; Liver; Liver Failure; Lung; Muscles; Phenylbutyrates; Sodium Benzoate	2011
Critical analysis of studies evaluating the efficacy of infusion of L-ornithine L-aspartate in clinical hepatic encephalopathy in patients with liver failure. Annals of hepatology, 2011, Volume: 10 Suppl 2 Topics: Adult; Aged; Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Liver Failure; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome	2011
[Hepatic encephalopathy and liver transplantation]. Magyar sebeszet, 2012, Volume: 65, Issue:2 Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome	2012
[Researching progress of prevention and treatment of hepatic failure encephalopathy]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2002, Volume: 10, Issue:4 Topics: Animals; Brain Edema; Cerebrovascular Circulation; Dipeptides; Hepatic Encephalopathy; Humans; Naloxone	2002
Clinical efficacy of L-ornithine-L-aspartate in the management of hepatic encephalopathy. Metabolic brain disease, 2002, Volume: 17, Issue:4 Topics: Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Muscular Diseases; Severity of Illness Index	2002
[Hepatic encephalopathy--therapy]. Deutsche medizinische Wochenschrift (1946), 2003, Dec-12, Volume: 128, Issue:50 Topics: Administration, Oral; Ammonia; Anti-Bacterial Agents; Diet, Protein-Restricted; Dipeptides; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Humans; Liver Diseases	2003
[New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects]. Gastroenterologia y hepatologia, 2004, Volume: 27 Suppl 1 Topics: Ammonia; Brain; Brain Edema; Dipeptides; Flumazenil; Glutaminase; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Inflammation; Intestine, Small; Kidney; Memantine; Models, Molecular; Nerve Tissue Proteins; Nitric Oxide	2004
The treatment of hepatic encephalopathy. Metabolic brain disease, 2007, Volume: 22, Issue:3-4 Topics: Amino Acids, Branched-Chain; Anti-Bacterial Agents; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols; Zinc	2007
[Ornithine aspartate in hepatic encephalopathy: an established new therapeutic approach. Overview and results of current randomized studies]. Zeitschrift fur arztliche Fortbildung, 1994, Volume: 88, Issue:9 Topics: Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Liver Function Tests; Randomized Controlled Trials as Topic; Treatment Outcome	1994
[Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient]. Fortschritte der Medizin, 1996, Apr-30, Volume: 114, Issue:12 Topics: Ammonia; Arginine; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Neuropsychological Tests; Prognosis; Psychometrics	1996
Review article: pathogenesis and treatment of chronic hepatic encephalopathy. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:5 Topics: Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Cerebral Cortex; Diet; Dipeptides; Disaccharides; Disease Models, Animal; Dopamine Agonists; Energy Metabolism; GABA Agents; Hepatic Encephalopathy; Humans; In Vitro Techniques; Intestinal Absorption; Neurotoxins; Synaptic Transmission; Tomography, Emission-Computed	1996

Trials

16 trial(s) available for ornithylaspartate and Encephalopathy, Hepatic

Article	Year
L-ornithine L-aspartate in bouts of overt hepatic encephalopathy. Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:2 Topics: Adult; Dipeptides; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Interleukins; Length of Stay; Male; Middle Aged; Prospective Studies	2018
Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo. European journal of gastroenterology & hepatology, 2018, Volume: 30, Issue:8 Topics: Adult; Ammonia; Biomarkers; Chi-Square Distribution; Dipeptides; Double-Blind Method; Female; Flicker Fusion; Hepatic Encephalopathy; Humans; India; Kaplan-Meier Estimate; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Neuropsychological Tests; Odds Ratio; Psychometrics; Recurrence; Risk Factors; Secondary Prevention; Sickness Impact Profile; Tertiary Care Centers; Time Factors; Treatment Outcome	2018
Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding. Canadian journal of gastroenterology & hepatology, 2018, Volume: 2018 Topics: Acute Disease; Adult; Dipeptides; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Rifaximin	2018
[Ornithine aspartate and naloxone combined therapy for hepatic encephalopathy affects cognitive function, prognosis, and neuropeptide levels]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2013, Volume: 21, Issue:5 Topics: Adult; Dipeptides; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged; Naloxone; Neuropeptides; Prognosis	2013
Randomised clinical trial: L-ornithine-L-aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. Alimentary pharmacology & therapeutics, 2014, Volume: 40, Issue:1 Topics: Adult; Ammonia; Dipeptides; Female; Hepatic Encephalopathy; Humans; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Postprandial Period; Psychometrics; Treatment Outcome	2014
L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2008, Volume: 18, Issue:11 Topics: Adult; Aged; Ammonia; Cognition; Dipeptides; Female; Health Status Indicators; Hepatic Encephalopathy; Humans; Hyperammonemia; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Postprandial Period	2008
A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:4 Topics: Aged; Ammonia; Biopsy, Needle; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Hepatic Encephalopathy; Humans; Immunohistochemistry; Infusions, Intravenous; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Pilot Projects; Postural Balance; Psychometrics; Reference Values; Risk Assessment; Sensation Disorders; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Treatment Outcome	2010
Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. Clinical drug investigation, 2011, Volume: 31, Issue:4 Topics: Administration, Oral; Adult; Aged; Dipeptides; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Quality of Life	2011
The effect of L-ornithine L-aspartate and branch chain amino acids on encephalopathy and nutritional status in liver cirrhosis with malnutrition. Acta medica Indonesiana, 2011, Volume: 43, Issue:1 Topics: Adult; Aged; Albumins; Amino Acids, Branched-Chain; Ammonia; Dietary Proteins; Dipeptides; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Male; Malnutrition; Middle Aged; Nutritional Status; Young Adult	2011
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:8 Topics: Adult; Ammonia; Dipeptides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neuropsychological Tests; Probiotics; Psychometrics; Quality of Life; Severity of Illness Index; Treatment Outcome	2011
Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2011, Volume: 21, Issue:11 Topics: Anti-Infective Agents; Dipeptides; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Glucose; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Lactulose; Length of Stay; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome	2011
[Therapeutic effect of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA, 2005, Volume: 25, Issue:6 Topics: Dipeptides; Female; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged	2005
[The treatment of hepatic encephalopathy with Hepa-Mertz]. Terapevticheskii arkhiv, 1995, Volume: 67, Issue:6 Topics: Ammonia; Biomarkers; Chronic Disease; Dipeptides; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Psychomotor Performance; Time Factors	1995
Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Hepatology (Baltimore, Md.), 1997, Volume: 25, Issue:6 Topics: Adult; Aged; Ammonia; Dipeptides; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Mental Health; Middle Aged; Placebos; Veins	1997
Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study. Journal of hepatology, 1998, Volume: 28, Issue:5 Topics: Administration, Oral; Adult; Ammonia; Dietary Proteins; Dipeptides; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Placebos; Postprandial Period	1998
[The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis]. Klinicheskaia meditsina, 2002, Volume: 80, Issue:5 Topics: Adult; Dipeptides; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged	2002

Other Studies

30 other study(ies) available for ornithylaspartate and Encephalopathy, Hepatic

Article	Year
Terminating and episode of overt hepatic encephalopathy: L-ornithine-L-aspartate may have some role. Hepatology (Baltimore, Md.), 2018, Volume: 67, Issue:2 Topics: Aspartic Acid; Dipeptides; Hepatic Encephalopathy; Humans; Ornithine	2018
Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials. Journal of cellular biochemistry, 2018, Volume: 119, Issue:10 Topics: Acetylcarnitine; Adult; Ammonia; Dipeptides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Network Meta-Analysis; Neuroprotective Agents; Probiotics; Randomized Controlled Trials as Topic; Rifaximin; Serum Albumin; Treatment Outcome	2018
L-Ornithine L-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic. Drugs, 2019, Volume: 79, Issue:Suppl 1 Topics: Astrocytes; Dipeptides; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Translational Research, Biomedical	2019
Possibilities of therapeutic correction of hyperammonemia and minimal hepatic encephalopathy in patients with chronic hepatitis C at the pre-cirrhotic stage. Terapevticheskii arkhiv, 2019, Mar-18, Volume: 91, Issue:2 Topics: Adult; Ammonia; Case-Control Studies; Dipeptides; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Hyperammonemia; Male; Treatment Outcome	2019
Modulation of neural activation following treatment of hepatic encephalopathy. Neurology, 2013, Mar-12, Volume: 80, Issue:11 Topics: Administration, Oral; Adult; Brain; Dipeptides; Female; Hepatic Encephalopathy; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Net; Psychomotor Performance; Treatment Outcome	2013
[Comparative effectiveness of different treatment methods of liver failure]. Khirurgiia, 2014, Issue:3 Topics: Comparative Effectiveness Research; Dipeptides; Extracorporeal Circulation; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Monitoring, Physiologic; Plasma Exchange; Sorption Detoxification; Treatment Outcome	2014
[Pathogenesis, diagnosis and treatment of hepatic encephalopathies in patients with liver cirrhosis]. Likars'ka sprava, 2014, Issue:11 Topics: Adult; Aged; Ammonia; Citric Acid Cycle; Dipeptides; Event-Related Potentials, P300; Female; Hepatic Encephalopathy; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Protective Agents; Severity of Illness Index	2014
[In Process Citation]. MMW Fortschritte der Medizin, 2015, Volume: 157 Suppl 2 Topics: Ammonia; Clinical Trials as Topic; Dipeptides; Early Diagnosis; Early Medical Intervention; Evidence-Based Medicine; Hepatic Encephalopathy; Humans; Lactulose; Prognosis; Rifamycins; Rifaximin	2015
[Options in the treatment of hepatic encephalopathy]. Medizinische Monatsschrift fur Pharmazeuten, 2015, Volume: 38, Issue:5 Topics: Amino Acids, Branched-Chain; Ammonia; Anti-Bacterial Agents; Dipeptides; Hepatic Encephalopathy; Humans; Rifamycins; Rifaximin	2015
Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs. Journal of veterinary science, 2016, Sep-30, Volume: 17, Issue:3 Topics: Ammonia; Animals; Dipeptides; Dog Diseases; Dogs; Female; Hepatic Encephalopathy; Hyperammonemia; Male	2016
Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine. Metabolic brain disease, 2016, Volume: 31, Issue:4 Topics: Adult; Brain; Caffeine; Dipeptides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Wakefulness	2016
A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy. Metabolic brain disease, 2017, Volume: 32, Issue:1 Topics: Adult; Aged; Brain; Cognition; Diffusion Magnetic Resonance Imaging; Dipeptides; Female; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Psychometrics	2017
[Hepatic encephalopathy. L-ornithine-L-aspartate stimulate detoxification capacity of the liver]. MMW Fortschritte der Medizin, 2010, Jun-03, Volume: 152, Issue:22 Topics: Ammonia; Clinical Trials as Topic; Dipeptides; Hepatic Encephalopathy; Humans; Liver; Liver Function Tests; Neuropsychological Tests	2010
[Reduction of hospital stay with the use of L-ornithine L-aspartate (LOLA) in patients with hepatic encephalopathy]. Revista de gastroenterologia de Mexico, 2010, Volume: 75, Issue:2 Topics: Adult; Aged; Dipeptides; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Length of Stay; Male; Middle Aged; Retrospective Studies	2010
Normal protein diet and L-ornithine-L-aspartate for hepatic encephalopathy. Acta medica Indonesiana, 2010, Volume: 42, Issue:3 Topics: Ammonia; Dietary Proteins; Dipeptides; Dose-Response Relationship, Drug; Follow-Up Studies; Hepatic Encephalopathy; Humans; Male; Middle Aged	2010
[Optimization of treatment of patients with chronic cardiac insufficiency of the ischemic genesis and hobnail liver]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2011, Volume: 56, Issue:5-6 Topics: Aged; Anti-Infective Agents; Comorbidity; Dipeptides; Drug Combinations; Female; Heart; Heart Failure; Hepatic Encephalopathy; Humans; Liver; Male; Middle Aged; Rifamycins; Rifaximin	2011
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Annals of hepatology, 2011, Volume: 10 Suppl 2 Topics: Administration, Oral; Ammonia; Dipeptides; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Quality of Life; Severity of Illness Index; Treatment Outcome; Urea	2011
Hepatic encephalopathy: nomenclature, pathogenesis and treatment. Revista espanola de enfermedades digestivas, 2003, Volume: 95, Issue:2 Topics: Anti-Bacterial Agents; Antifungal Agents; Bromocriptine; Dipeptides; Dopamine Agonists; Electroencephalography; Flumazenil; GABA Modulators; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure, Acute; Liver Transplantation; Neomycin; Nutritional Physiological Phenomena; Practice Guidelines as Topic; Prognosis; Sodium Benzoate; Terminology as Topic; Time Factors; Zinc	2003
[Because hepatic encephalopathy is a frequent contributing factor. Patients with liver cirrhosis are poorer drivers]. MMW Fortschritte der Medizin, 2003, Nov-20, Volume: 145, Issue:47 Topics: Accidents, Traffic; Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Liver Cirrhosis	2003
[Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain]. MMW Fortschritte der Medizin, 2004, Jan-29, Volume: 146, Issue:5 Topics: Ammonia; Clinical Trials as Topic; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Quality of Life; Self-Help Groups	2004
[Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)]. Zeitschrift fur Gastroenterologie, 2005, Volume: 43, Issue:4 Topics: Adult; Ammonia; Brain; Choline; Combined Modality Therapy; Creatinine; Diet, Protein-Restricted; Dipeptides; Energy Metabolism; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Inositol; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Prospective Studies; Reference Values; Statistics as Topic	2005
Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy. Metabolic brain disease, 2005, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Antiparkinson Agents; Benzothiazoles; Brain; Chronic Disease; Dipeptides; Evoked Potentials, Visual; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Paromomycin; Pramipexole; Recovery of Function; Thiazoles; Treatment Outcome; Vision Disorders	2005
Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction. Metabolic brain disease, 2007, Volume: 22, Issue:1 Topics: Aged; Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Liver Diseases, Alcoholic; Liver Transplantation; Male; Portasystemic Shunt, Transjugular Intrahepatic; Postoperative Complications; Stents	2007
[New approach to diagnostics and correction of portohepatic hemodynamics in patients with chronic liver diseases]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2007, Issue:4 Topics: Adult; Dipeptides; Female; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Hypertension, Portal; Liver Circulation; Male; Retrospective Studies; Treatment Outcome	2007
Contrasting effects of thioacetamide-induced liver damage on the brain uptake indices of ornithine, arginine and lysine: modulation by treatment with ornithine aspartate. Metabolic brain disease, 1996, Volume: 11, Issue:3 Topics: Animals; Arginine; Blood-Brain Barrier; Brain; Chemical and Drug Induced Liver Injury; Dipeptides; Hepatic Encephalopathy; Infusions, Intravenous; Lysine; Male; Ornithine; Rats; Rats, Wistar; Thioacetamide	1996
L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action. Metabolic brain disease, 1998, Volume: 13, Issue:2 Topics: Ammonia; Animals; Dipeptides; Glutamic Acid; Hepatic Encephalopathy; Male; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley; Urea	1998
[Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?]. MMW Fortschritte der Medizin, 2000, Jun-22, Volume: 142, Issue:25 Topics: Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin	2000
[In liver cirrhosis, not every "ammonia lowering drug" improves neuropsychiatric deficit]. MMW Fortschritte der Medizin, 2001, Mar-01, Volume: 143, Issue:9 Topics: Clinical Trials as Topic; Dipeptides; Hepatic Encephalopathy; Hyperammonemia; Neuropsychological Tests; Treatment Outcome	2001
[Chronic liver diseases. The nihilism has gone]. MMW Fortschritte der Medizin, 2001, Dec-13, Volume: 143, Issue:51-52 Topics: Amantadine; Antioxidants; Antiviral Agents; Chronic Disease; Dipeptides; Drug Therapy, Combination; Flumazenil; GABA Modulators; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Liver Diseases; Pentoxifylline; Phosphodiesterase Inhibitors; Prospective Studies; Protective Agents; Ribavirin; Silymarin	2001
Proton MR spectroscopy of neurometabolites in hepatic encephalopathy during L-ornithine-L-aspartate treatment--results of a pilot study. Metabolic brain disease, 2002, Volume: 17, Issue:2 Topics: Aged; Brain; Creatine; Dipeptides; Female; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Pilot Projects; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome	2002